MedPath

Investigating the in vivo bioequivalence of Effavirenz/Emtricitabine/Tenofovir tablet

Not Applicable
Recruiting
Conditions
.
Registration Number
IRCT20220211053992N29
Lead Sponsor
Tabriz University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
24
Inclusion Criteria

General Health (in terms of Liver, Heart and Kidney)

Exclusion Criteria

Smoking
History of cardiovascular disease, liver and kidney disease
Pregnancy
Alcohol and drug addiction
History of drug allergy

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.